Lipocine (LPCN) Misses Q3 EPS by 67c

Lipocine (NASDAQ: LPCN) reported Q3 EPS of ($1.27), $0.67 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• DA Davidson flags Duolingo DAU momentum stalling, keeps Neutral at $120
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'